Does DABIGATRAN Cause Hypovolaemia? 19 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Hypovolaemia have been filed in association with DABIGATRAN. This represents 0.9% of all adverse event reports for DABIGATRAN.
19
Reports of Hypovolaemia with DABIGATRAN
0.9%
of all DABIGATRAN reports
0
Deaths
19
Hospitalizations
How Dangerous Is Hypovolaemia From DABIGATRAN?
Of the 19 reports, 19 (100.0%) required hospitalization.
Is Hypovolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABIGATRAN. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does DABIGATRAN Cause?
Gastrointestinal haemorrhage (210)
Hypotension (167)
Atrial fibrillation (150)
Drug interaction (143)
Haemorrhage (141)
Anaemia (131)
Dizziness (123)
Acute kidney injury (120)
Drug ineffective (118)
Fall (117)
What Other Drugs Cause Hypovolaemia?
FUROSEMIDE (346)
METFORMIN (281)
EMPAGLIFLOZIN (150)
SPIRONOLACTONE (123)
DEXAMETHASONE (117)
HYDROCHLOROTHIAZIDE (94)
PREDNISONE (91)
LISINOPRIL (86)
METOPROLOL (84)
ACETAMINOPHEN (77)
Which DABIGATRAN Alternatives Have Lower Hypovolaemia Risk?
DABIGATRAN vs DABIGATRAN ETEXILATE
DABIGATRAN vs DABRAFENIB
DABIGATRAN vs DABRAFENIB\TRAMETINIB
DABIGATRAN vs DACARBAZINE
DABIGATRAN vs DACLATASVIR